tert-Butyl 4-(6-Nitropyridin-3-yl)piperazinum-1-carboxylatum CAS 571189-16-7 Purity >98.0% (HPLC)

Description:

Nomen chemica: tert-Butyl 4-(6-nitropyridinum-3-yl) piperazinum-1-carboxylatum

Synonyma: 1-Boc-4-(6-Nitro-3-pyridyl) piperazinum

CAS: 571189-16-7

Puritas: >98.0% (HPLC)

Aspectus: Lumen Brown ad Pulverem Brown

Medium Palbociclib (CAS: 571190-30-2)

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ruifu Chemical Supple Palbociclib Intermedia:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidines CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl) piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-pyridyl) piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-one CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-pyrido[2,3-d]pyrimidin-7-one CAS 1013916-37-4

Chemical Properties:

Nomen chemicum	tert-Butyl 4-(6-nitropyridin-3-yl) piperazine-1-carboxylata
Synonyma	1-Boc-4-(6-Nitro-3-Pyridyl) piperazine;4-(6-Nitro-3-pyridinyl) -1-Piperazinecarboxylic Acidum tert-Butyl Ester;tert-Butyl 4-(6-Nitro-3-pyridinyl) -1-Piperazinecarboxylate.
CAS Number	571189-16-7
CATTUS Number	RF-PI1850
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C14H20N4O4
M. Pondus	308.33
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Lumen Brown to Brown Pulvis
Puritas / Analysis Methodus	>98.0% (HPLC)
LCMS	Congruunt cum Structure
Damnum in Siccatio	<1.00%
Totalis immunditias	<2.00%
Test Standard	Enterprise Standard
Consuetudinem	Medium Palbociclib (CAS: 571190-30-2)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

tert-Butyl 4-(6-nitropyridin-3-yl)piperazinum-1-carboxylatum (CAS: 571189-16-7) medium est Palbociclib (CAS: 571190-30-2).Palbociclib (quoque notus numerus compositorum PD-0332991) experimentale medicamentum est ad curationem cancri pectoris a Pfizer crescendo.Inhibitor selectivorum cyclini-dependens kinases CDK4 et CDK6 est.Palbociclib impedit progressionem cycli cellulae a phase G1 in S, inhibendo CDK4/6-dependens retinoblastoma (RB) phosphorylationis.Palbociclibhas adhibita est pro curatione HER2 negativa, receptor estrogen (ER) metastatica cancer pectoris positive.